Ask AI

2022 FALL PCE ONCOLOGY CONFERENCE SERIES EVALUATIONS

Learn about the latest strategies, guidelines, and developments in therapies to best manage and care for your patients!

Share

Program Content

Activities

  • Exploring the Latest Advances in Basal Cell Carcinoma
    Exploring the Latest Advances in Basal Cell Carcinoma
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Applying the Expanding Range of Options for Advanced Gastric Cancer
    Applying the Expanding Range of Options for Advanced Gastric Cancer
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Treating Gynecologic Cancers: Current Approaches to Patient Care
    Treating Gynecologic Cancers: Current Approaches to Patient Care
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Living Longer With HER2+ Breast Cancer: Sequencing Newer Therapies to Improve Survival
    Living Longer With HER2+ Breast Cancer: Sequencing Newer Therapies to Improve Survival
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors
    Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Advances in Immune Checkpoint Inhibitor Therapy for Patients with Non-Small-Cell Lung Cancer: Applications to Clinical Practice
    Advances in Immune Checkpoint Inhibitor Therapy for Patients with Non-Small-Cell Lung Cancer: Applications to Clinical Practice
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • PARP Inhibitors as Precision Medicine in Metastatic Prostate Cancer
    PARP Inhibitors as Precision Medicine in Metastatic Prostate Cancer
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022
  • Patient Panel Talk
    Patient Panel Talk
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022